Neuroscience Antibodies and Assays Market Emerging Trends, Business Growth Opportunities, Major Driving Factors

Press Release

Antibody, also known as immunoglobulin, is a Y-shaped protein found in blood or other body fluids. It is produced by immune system as a response to the presence of antigen. Neuroscience is a heterogeneous field which involves the structure and functions of the human brain and nervous system. It requires an integrated analysis of multiple cell types, tissues, and organs. Antibodies based approaches are used for isolation.

Obtain Report Details @

Increasing demand for high-quality antibodies due to discovery of new potential drug target, signaling molecules, and structural protein in the brain, availability of antibody-based biomarker detection reagent for numerous cell and tissue types, and growing recognition of the role of anti-brain specific autoantibodies in human diseases are some of the factors which are likely to propel the global neuroscience antibodies and assays market during the forecast period.

However, stringent regulatory authorities and reported cases of adverse immune response against antibodies from different source in certain people are anticipated to impact the global neuroscience antibodies and assays market. Customized antibodies for personalized treatment and diagnosis of neurological disorders is a new trend which is likely to boost the growth of the market.

The global neuroscience antibodies and assays market can be categorized based on product type, indication, technology, end-user, and region. On the basis of product type, the market can be divided into consumables and instruments. The consumable segment can be sub-divided into reagents (media & sera, stains & dyes, fixatives, buffers, solvents, probes, enzymes, proteins, and peptides), antibodies (primary antibodies, secondary antibodies, and assay. The instruments segment can be further categorized into microplate readers, immunoassay analyzers, and others.

Request Report Brochure @

Based on indication, the global neuroscience antibodies and assays market can be segmented into Alzheimer’s disease, Parkinson’s disease, Multiple sclerosis (MS), prion disease, Amyotrophic lateral sclerosis (ALS), and others. According to Alzheimer’s disease International, 46.5 million people were estimated to be suffering from dementia in 2015. Alzheimer’s disease is the leading segment of the market, expected to propel the growth of neuroscience antibodies and assays market as it is one of the highly prevailing neurological disorders in the world.

In terms of technology, the market can be classified into immunochemistry, clinical chemistry, molecular diagnostics, and others. The immunochemistry segment can be further divided into enzyme-linked immunosorbent assay (ELISA), western blotting, and other immunoassay technologies. On the basis of end user, the global neuroscience antibodies and assays market can be divided into hospitals, clinics, research laboratories, in vitro diagnostics labs, and others. Research laboratories are expected to propel the growth the neuroscience antibodies and assays market during the forecast period due to increase in investment in R&D for quality assurance of neuroscience antibodies and assay kits.

Request for TOC @

In terms of region, the global neuroscience antibodies and assays market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Neurological disease is widespread all over the world, in which, North America holds the leading share of the global neuroscience antibodies and assay treatment market, followed by Europe. This can be attributed to factors, such as, growth initiatives and funding by various organizations to support the development of new treatments and assays for neurological disorders. The neuroscience antibodies and assays market in Europe is likely to exhibit significant growth due to increasing research and development activities adopted by the key market players present in the region.

The global neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. In 2017, Thermo Fisher Scientific, Abcam, Bio-Rad, and Merck KGaA were the leading players in the global neuroscience antibodies and assays market. Other major players include BioLegend, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, Rockland Immunochemicals, Santa Cruz Biotechnology, Siemens, and Tecan.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453


Related Articles